diethylnitrosamine has been researched along with verapamil in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fardel, O; Glaise, D; Guillouzo, A; Lecureur, V; Loyer, P | 1 |
| Abo Mansour, HE; Abo-Elmatty, DM; Badawy, NS; El-Batsh, MM; Mehanna, ET; Mesbah, NM | 1 |
2 other study(ies) available for diethylnitrosamine and verapamil
| Article | Year |
|---|---|
Constitutive expression of functional P-glycoprotein in rat hepatoma cells.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Carcinoma, Hepatocellular; Carrier Proteins; Clone Cells; Cycloheximide; Diethylnitrosamine; Doxorubicin; Drug Resistance; Female; Gene Expression; Glutathione Transferase; Liver Neoplasms; Membrane Glycoproteins; Rats; Rats, Sprague-Dawley; RNA, Messenger; RNA, Neoplasm; Serum Albumin; Transcription, Genetic; Tumor Cells, Cultured; Verapamil | 1994 |
Effect of co-treatment with doxorubicin and verapamil loaded into chitosan nanoparticles on diethylnitrosamine-induced hepatocellular carcinoma in mice.
Topics: Animals; Antibiotics, Antineoplastic; Apoptosis; Calcium Channel Blockers; Carcinoma, Hepatocellular; Cardiotoxicity; Cell Survival; Chitosan; Diethylnitrosamine; Doxorubicin; Drug Combinations; Drug Delivery Systems; Hep G2 Cells; Humans; Liver; Liver Neoplasms; Male; Malondialdehyde; Mice; Myocardium; Nanoparticles; Proto-Oncogene Proteins c-bcl-2; Tumor Necrosis Factor-alpha; Vascular Endothelial Growth Factor A; Verapamil | 2020 |